Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results

Darell D. Bigner, Mark T. Brown, Allan H. Friedman, R. Edward Coleman, Gamal Akabani, Henry S. Friedman, Wade L. Thorstad, Roger E. McLendon, Sandra H. Bigner, Xiao Guang Zhao, Charles N. Pegram, Carol J. Wikstrand, James E. Herndon, Nicholas A. Vick, Nina Paleologos, Ilkcan Cokgor, James M. Provenzale, Michael R. Zalutsky

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Fingerprint

Dive into the research topics of 'Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science